RE Harris

751 total citations
12 papers, 608 citations indexed

About

RE Harris is a scholar working on Pharmacology, Oncology and Genetics. According to data from OpenAlex, RE Harris has authored 12 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Oncology and 3 papers in Genetics. Recurrent topics in RE Harris's work include Inflammatory mediators and NSAID effects (3 papers), Estrogen and related hormone effects (3 papers) and Cancer Risks and Factors (3 papers). RE Harris is often cited by papers focused on Inflammatory mediators and NSAID effects (3 papers), Estrogen and related hormone effects (3 papers) and Cancer Risks and Factors (3 papers). RE Harris collaborates with scholars based in United States and United Kingdom. RE Harris's co-authors include Michelle L. Parrett, Fredika M. Robertson, Hussein Abou‐Issa, Galal A. Alshafie, Kathryn P. Clausen, Mitchell P. Ross, Karen Seibert, K.K. Namboodiri, Ernst L. Wynder and Barbara A. Horwitz and has published in prestigious journals such as American Journal of Clinical Nutrition, JNCI Journal of the National Cancer Institute and International Journal of Gynecology & Obstetrics.

In The Last Decade

RE Harris

12 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
RE Harris United States	8	315	312	151	129	82	12	608
John Kemp United Kingdom	14	208 0.7×	65 0.2×	189 1.3×	93 0.7×	109 1.3×	23	652
Susan Loftus United States	6	89 0.3×	243 0.8×	147 1.0×	63 0.5×	89 1.1×	10	579
Pritha Bhadra United States	7	153 0.5×	628 2.0×	256 1.7×	150 1.2×	140 1.7×	9	1.1k
Randall Harris United States	8	291 0.9×	165 0.5×	314 2.1×	69 0.5×	109 1.3×	9	769
J-F Boivin Canada	6	143 0.5×	124 0.4×	73 0.5×	105 0.8×	34 0.4×	8	323
Andria L. Del Tredici United States	14	200 0.6×	105 0.3×	109 0.7×	56 0.4×	191 2.3×	28	835
Beatrice Oneda Switzerland	12	153 0.5×	89 0.3×	129 0.9×	175 1.4×	163 2.0×	25	734
K. I. Pritchard Canada	8	219 0.7×	53 0.2×	247 1.6×	46 0.4×	75 0.9×	25	563
Frank G. Bottone United States	15	73 0.2×	172 0.6×	65 0.4×	36 0.3×	264 3.2×	23	744
Megan Kane United States	11	98 0.3×	68 0.2×	85 0.6×	64 0.5×	259 3.2×	28	660

Countries citing papers authored by RE Harris

Since Specialization

Citations

This map shows the geographic impact of RE Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RE Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RE Harris more than expected).

Fields of papers citing papers by RE Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RE Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RE Harris. The network helps show where RE Harris may publish in the future.

Co-authorship network of co-authors of RE Harris

This figure shows the co-authorship network connecting the top 25 collaborators of RE Harris. A scholar is included among the top collaborators of RE Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RE Harris. RE Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Alshafie, Galal A., Hussein Abou‐Issa, Karen Seibert, & RE Harris. (2000). Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model.. Oncology Reports. 7(6). 1377–81. 140 indexed citations

2.

Stern, Jeremy S., et al.. (1997). Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia. American Journal of Clinical Nutrition. 66(4). 890–903. 69 indexed citations

3.

Parrett, Michelle L., et al.. (1997). Cyclooxygenase-2 gene expression in human breast cancer. International Journal of Oncology. 10(3). 503–7. 219 indexed citations

4.

Abou‐Issa, Hussein, et al.. (1997). Growth arrest of DMBA-induced mammary carcinogenesis with ibuprofen treatment in female Sprague-Dawley rats. Oncology Reports. 4(6). 1271–3. 18 indexed citations

5.

Harris, RE, et al.. (1993). 92323839 Breast cancer risk Effects of estrogen replacement therapy and body mass. Maturitas. 16(3). 214–215. 2 indexed citations

6.

Harris, RE, K.K. Namboodiri, & Ernst L. Wynder. (1992). Breast Cancer Risk: Effects of Estrogen Replacement Therapy and Body Mass. JNCI Journal of the National Cancer Institute. 84(20). 1575–1582. 73 indexed citations

7.

Wynder, E L & RE Harris. (1989). Does alcohol consumption influence the risk of developing breast cancer? Two views.. PubMed. 283–93. 18 indexed citations

8.

Muscat, Joshua, RE Harris, Nancy J. Haley, & E. L. Wynder. (1989). Population screening for plasma cholesterol: community-based results from Memphis.. PubMed. 82(12). 633–9. 2 indexed citations

9.

Harris, RE, Nancy J. Haley, Joshua Muscat, & E. L. Wynder. (1989). Population screening for plasma cholesterol: community-based results from Miami.. PubMed. 76(10). 853–60. 5 indexed citations

10.

Harris, RE & E L Wynder. (1989). Breast cancer and alcohol consumption. A study in weak associations. International Journal of Gynecology & Obstetrics. 28(2). 203–203. 5 indexed citations

11.

Linn, Margaret W., Bernard S. Linn, & RE Harris. (1982). EFFECTS OF COUNSELING FOR LATE STAGE CANCER. 49(5). 1048–1055. 19 indexed citations

12.

christian, j. c., et al.. (1976). Effects of chorion type on variation in cord blood cholesterol of monozygotic twins.. PubMed. 28(5). 433–41. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact